OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $181.9 million versus the consensus estimate of $177.53 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.